New & Noteworthy

April 2019

Droperiodol Injection, USP

American Regent, Inc

American Regent has reintroduced Droperidol Injection, USP, which is AP-rated and therapeutically equivalent to Inapsine. It is indicated to reduce the incidence of nausea and vomiting associated with surgical and diagnostic procedures. The strength is 5 mg/2 mL, supplied in a 2 mL single-dose vial. The NDC is 00517-9702-01.

American Regent, Inc

Request More Information

Current Issue